Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas

被引：57

作者：

Bebear, CM

Renaudin, H

Bryskier, A

Bebear, C

机构：

[1] Univ Bordeaux 2, Bacteriol Lab, F-33076 Bordeaux, France

[2] Hoechst Marion Roussel, F-93235 Romainville, France

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2000年 / 44卷 / 07期

关键词：

D O I：

10.1128/AAC.44.7.1980-1982.2000

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The activities of telithromycin and levofloxacin against 99 mycoplasma strains were compared to those of several macrolides, ofloxacin, and doxycycline. Telithromycin MICs of less than or equal to 0.25 mu g/ml were found for all isolates, except for Mycoplasma hominis, while levofloxacin was active at concentrations of less than or equal to 1 mu g/ml against all species studied.

引用

收藏

页码：1980 / 1982

页数：3

相关论文

共 17 条

[1]

[Anonymous], MOL DIAGNOSTIC PROCE

[2] Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis [J].

Bebear, CM ;

Renaudin, J ;

Charron, A ;

Renaudin, H ;

de Barbeyrac, B ;

Schaeverbeke, T ;

Bebear, C .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) :954-956

[3] In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas [J].

Bébéar, CM ;

Renaudin, H ;

Schaeverbeke, T ;

Leblanc, F ;

Bébéar, C .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (05) :711-714

[4] In-vitro activity of ketolides against mycoplasmas [J].

Bebear, CM ;

Renaudin, H ;

Aydin, MD ;

Chantot, JF ;

Bebear, C .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (05) :669-670

[5] In vitro activity of BAY 12-8039, a new fluoroquinolone, against mycoplasmas [J].

Bébéar, CM ;

Renaudin, H ;

Boudjadja, A ;

Bébéar, C .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) :703-704

[6]

Bryskier A, 1997, INFEC DIS T, V21, P39

[7] Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219) [J].

Kenny, GE ;

Cartwright, FD .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) :1048-1049

[8] In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria [J].

Malathum, K ;

Coque, TM ;

Singh, KV ;

Murray, BE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) :930-936

[9] NEW QUINOLONES AND GRAM-POSITIVE BACTERIA [J].

PIDDOCK, LJV .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (02) :163-169

[10] The in-vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum and Legionella spp. [J].

Ridgway, GL ;

Salman, H ;

Robbins, MJ ;

Dencer, C ;

Felmingham, D .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 :31-34